These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37914199)

  • 1. What is the role for terlipressin in hepatorenal syndrome?
    Bass SN; Kapoor A; Lindenmeyer CC
    Cleve Clin J Med; 2023 Nov; 90(11):664-667. PubMed ID: 37914199
    [No Abstract]   [Full Text] [Related]  

  • 2. Terlipressin for the treatment of hepatorenal syndrome: an overview of current evidence.
    Zhang J; Rössle M; Zhou X; Deng J; Liu L; Qi X
    Curr Med Res Opin; 2019 May; 35(5):859-868. PubMed ID: 30474439
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications].
    Liu CH; Xing F; Wang J
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):929-932. PubMed ID: 31941255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Responsiveness to Vasoconstrictor Therapy in Hepatorenal Syndrome Type 1.
    Velez JCQ; Karakala N; Tayebi K; Wickman TJ; Mohamed MMB; Kovacic RA; Therapondos G; Kanduri SR; Allegretti AS; Belcher JM; Regner KR; Wentowski C
    Kidney360; 2023 Apr; 4(4):e448-e456. PubMed ID: 36763632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Terlipressin and albumin combination treatment in patients with hepatorenal syndrome type 2.
    Nguyen-Tat M; Jäger J; Rey JW; Nagel M; Labenz C; Wörns MA; Galle PR; Marquardt JU
    United European Gastroenterol J; 2019 May; 7(4):529-537. PubMed ID: 31065370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of treatment with terlipressin plus albumin in hepatorenal syndrome diagnosed with the new acute kidney injury versus the conventional criteria.
    Kalambokis GN; Christaki M; Tsiakas I; Despotis G; Milionis HJ
    Eur J Gastroenterol Hepatol; 2019 Oct; 31(10):1292-1294. PubMed ID: 31498285
    [No Abstract]   [Full Text] [Related]  

  • 7. Noradrenaline as an alternative medical treatment to terlipressin in the management of hepatorenal syndrome type 1.
    Sendra C; Silva Ruiz MDP; Ferrer Rios MT; Alarcón García JC; Pascasio Acevedo JM
    Gastroenterol Hepatol; 2018; 41(7):440-441. PubMed ID: 29054321
    [No Abstract]   [Full Text] [Related]  

  • 8. Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 With Terlipressin.
    Gonzalez SA; Velez JCQ
    Am J Gastroenterol; 2022 Apr; 117(4):520-523. PubMed ID: 35029160
    [No Abstract]   [Full Text] [Related]  

  • 9. Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome.
    Wong F; Pappas SC; Curry MP; Reddy KR; Rubin RA; Porayko MK; Gonzalez SA; Mumtaz K; Lim N; Simonetto DA; Sharma P; Sanyal AJ; Mayo MJ; Frederick RT; Escalante S; Jamil K;
    N Engl J Med; 2021 Mar; 384(9):818-828. PubMed ID: 33657294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Terlipressin and albumin in patients with cirrhosis and type I hepatorenal syndrome.
    Neri S; Pulvirenti D; Malaguarnera M; Cosimo BM; Bertino G; Ignaccolo L; Siringo S; Castellino P
    Dig Dis Sci; 2008 Mar; 53(3):830-5. PubMed ID: 17939047
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Respiratory Complications in Alcoholic Hepatitis Patients With Hepatorenal Syndrome When Treated With Terlipressin: Is it Safe?
    Ariga KK; Verma G; Agrawal D
    Clin Gastroenterol Hepatol; 2023 Nov; 21(12):3197-3198. PubMed ID: 37031717
    [No Abstract]   [Full Text] [Related]  

  • 12. Terlipressin for hepatorenal syndrome: opportunities and challenges.
    Singal AK; Jalan R
    Lancet Gastroenterol Hepatol; 2023 Feb; 8(2):104-106. PubMed ID: 36620975
    [No Abstract]   [Full Text] [Related]  

  • 13. Targeting circulatory dysfunction in cirrhosis: terlipressin and the hepatorenal syndrome.
    Testro AG; Angus PW
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1707-9. PubMed ID: 20136956
    [No Abstract]   [Full Text] [Related]  

  • 14. Real-world treatment patterns and outcomes using terlipressin in 203 patients with the hepatorenal syndrome.
    Moore K; Jamil K; Verleger K; Luo L; Kebede N; Heisen M; Corman S; Leonardi R; Bakker R; Maï C; Shamseddine N; Huang X; Allegretti AS
    Aliment Pharmacol Ther; 2020 Jul; 52(2):351-358. PubMed ID: 32495956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. First Drug for Treating Hepatorenal Syndrome.
    Aschenbrenner DS
    Am J Nurs; 2023 Feb; 123(2):27. PubMed ID: 36698358
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome.
    Kim HR; Lee YS; Yim HJ; Lee HJ; Ryu JY; Lee HJ; Yoon EL; Lee SJ; Hyun JJ; Jung SW; Koo JS; Choung RS; Lee SW; Choi JH
    Clin Mol Hepatol; 2013 Dec; 19(4):417-20. PubMed ID: 24459647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Terlipressin versus placebo or no intervention for people with cirrhosis and hepatorenal syndrome.
    Allegretti AS; Israelsen M; Krag A; Jovani M; Goldin AH; Schulman AR; Winter RW; Gluud LL
    Cochrane Database Syst Rev; 2017 Jun; 6(6):CD005162. PubMed ID: 29943803
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and short-term outcome of hepatorenal syndrome: A 9-year experience in a high-complexity hospital in Colombia.
    Rey R M; Delgado AF; De Zubiria A; Pinto R; De la Hoz-Valle JA; Pérez-Riveros ED; Ardila G; Sierra-Arango F
    PLoS One; 2020; 15(10):e0239834. PubMed ID: 33079947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ischemic Skin Necrosis in Hepatorenal Syndrome Patient Secondary to Terlipressin.
    Ahmed R; Haseeb A
    J Coll Physicians Surg Pak; 2019 Jun; 29(6):S26-S28. PubMed ID: 31142412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Practical Management of HRS-AKI in the Era of Terlipressin: What the Gastroenterologist Needs to Know.
    Wong F; Kwo P
    Am J Gastroenterol; 2023 Jun; 118(6):915-920. PubMed ID: 36692387
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.